THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
基本信息
- 批准号:6220556
- 负责人:
- 金额:$ 0.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A prospective study of the prevalence, incidence, clinical characteristics, prognostic features, and pathologic description of cystic fibrosis arthropathy (CFA). CFA is characterized by recurrent, often painful bouts of mono-or polyarthritis. Many patients also manifest an erythema-nodosum-like rash, or in a few cases, purpuric skin lesions. The flares of joint inflammation last from one day to several weeks. Some patients with CFA progress to a chronic arthritis that can be quite debilitating. The appropriate treatment of CFA is not known and has not been studied in a large prospective study. The study is being performed simultaneously at Children's Hospital and The Massachusetts General Hospital as a combined effort of the Rheumatology Departments and Cystic Fibrosis Centers at each institution. The study entails screening for the presence of CFA with a questionnaire and follow-up medical chart review, physical exam, laboratory tests and selective radiographs. The study seeks to advance both the clinical and basic scientific knowledge of CFA and possibly gain insight into possible preventive or treatment measures.
囊性纤维性关节病(CFA)的患病率、发病率、临床特征、预后特征和病理描述的前瞻性研究。CFA的特点是反复发作,通常是疼痛的单发性或多发性关节炎。许多患者还表现为结节红斑样皮疹,或少数病例出现紫癜性皮损。关节炎症的症状持续一天到几周。一些患有CFA的患者进展为慢性关节炎,可能会相当虚弱。CFA的适当治疗尚不清楚,也没有在一项大型前瞻性研究中进行研究。这项研究同时在儿童医院和马萨诸塞州综合医院进行,两家医院的风湿科和囊性纤维化中心共同努力。这项研究包括通过问卷筛查CFA的存在,以及后续的病历复查、体检、实验室测试和选择性X光检查。这项研究旨在促进CFA的临床和基本科学知识,并可能获得对可能的预防或治疗措施的洞察。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT SUNDEL其他文献
ROBERT SUNDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT SUNDEL', 18)}}的其他基金
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
- 批准号:
6120776 - 财政年份:1998
- 资助金额:
$ 0.07万 - 项目类别:
TREATMENT OF KAWASAKI DISEASE--PULSE IV METHYLPREDNISOLONE VS IVIG
川崎病的治疗--PULSE IV甲泼尼龙VS IVIG
- 批准号:
6120816 - 财政年份:1998
- 资助金额:
$ 0.07万 - 项目类别:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
- 批准号:
6281395 - 财政年份:1997
- 资助金额:
$ 0.07万 - 项目类别:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
- 批准号:
6251893 - 财政年份:1997
- 资助金额:
$ 0.07万 - 项目类别:
TREATMENT OF KAWASAKI DISEASE--PULSE IV METHYLPREDNISOLONE VS IVIG
川崎病的治疗--PULSE IV甲泼尼龙VS IVIG
- 批准号:
6281435 - 财政年份:1997
- 资助金额:
$ 0.07万 - 项目类别:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
- 批准号:
5223796 - 财政年份:
- 资助金额:
$ 0.07万 - 项目类别:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
囊性纤维化关节病的患病率和临床特征
- 批准号:
6308988 - 财政年份:
- 资助金额:
$ 0.07万 - 项目类别:
相似海外基金
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
$ 0.07万 - 项目类别:
Collaborative R&D
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
合理优化治疗罕见囊性纤维化变异的组合疗法
- 批准号:
10736732 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Operating Grants
Analysis of synthetic derivatives with reduced lipophilicity as candidate potentiators towards better treatment alternatives for Cystic Fibrosis
分析亲脂性降低的合成衍生物作为候选增效剂,以获得更好的囊性纤维化治疗替代方案
- 批准号:
481159 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis
开发用于治疗囊性纤维化的基因编辑疗法、可生物降解的聚合物递送载体和高通量平台
- 批准号:
10836095 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
A Ginsenoside TMEM16A Potentiator for Cystic Fibrosis
人参皂苷 TMEM16A 治疗囊性纤维化的增效剂
- 批准号:
10574384 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies
用于基于 mRNA 的囊性纤维化治疗的非病毒基因传递载体的计算启发设计
- 批准号:
10760605 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Health Outcomes of Parents with Cystic Fibrosis (HOPe:CF)
患有囊性纤维化的父母的健康结果 (HOPe:CF)
- 批准号:
10581321 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Preparation for lung transplant discussions and decisions among people with cystic fibrosis
囊性纤维化患者肺移植讨论和决策的准备
- 批准号:
10657027 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别: